Related references
Note: Only part of the references are listed.Recent developments in the diagnosis and treatment of status epilepticus
Megan Selvitelli et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2007)
Reversible hepatotoxicity, pancreatitis, coagulation disorder and simultaneous bone marrow suppression with valproate in a 2-year-old girl
Thorsten Gerstner et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2007)
Randomized study of intravenous valproate and phenytoin in status epilepticus
Puneet Agarwal et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2007)
The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
G. Rosenberg
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Valproate selectively reduces EEG activity in anterior parts of the cortex in patients with idiopathic generalized epilepsy -: A low resolution electromagnetic tomography (LORETA) study
Clemens Bela et al.
EPILEPSY RESEARCH (2007)
Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy
Jee Young Kim et al.
EPILEPSIA (2007)
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model
Caroline Rouaux et al.
JOURNAL OF NEUROSCIENCE (2007)
Valproic acid-induced pancreatitis: 16 new cases and a review of the literature
Thorsten Gerstner et al.
JOURNAL OF GASTROENTEROLOGY (2007)
Valproic acid-induced hepatopathy:: Nine new fatalities in Germany from 1994 to 2003
Stephan A. Koenig et al.
EPILEPSIA (2006)
Oral rapid loading of valproic acid -: An alternative to the usual saturation scheme?
Thorsten Gerstner et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2006)
Valproic acid induced encephalopathy - 19 new cases in Germany from 1994 to 2003 - A side effect associated to VPA-therapy not only in young children
Thorsten Gerstner et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2006)
Valproate-associated coagulopathies are frequent and variable in children
Thorsten Gerstner et al.
EPILEPSIA (2006)
Insulin-related metabolic changes during treatment with valproate in patients with epilepsy
Virpi Pylvanen et al.
EPILEPSY & BEHAVIOR (2006)
Role of valproate across the ages. Treatment of epilepsy in children
A. Aldenkamp et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Acute hyperammonemic coma with chronic valproic acid therapy
M Cuturic et al.
ANNALS OF PHARMACOTHERAPY (2005)
Science review: Carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
PER Lheureux et al.
CRITICAL CARE (2005)
Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit
JG Boggs et al.
EPILEPSIA (2005)
Pancreatitis, complicated by a pancreatic pseudocyst associated with the use of valproic acid
ML Houben et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2005)
Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3
AJ Kim et al.
JOURNAL OF CELL SCIENCE (2005)
Valproic acid blood genomic expression patterns in children with epilepsy - a pilot study
Y Tang et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Factor XIII deficiency associated with valproate treatment
M Teich et al.
EPILEPSIA (2004)
Valproate potentiates androgen biosynthesis in human ovarian theca cells
VL Nelson-DeGrave et al.
ENDOCRINOLOGY (2004)
Severe myoclonic epilepsy in infancy: Toward an optimal treatment
B Ceulemans et al.
JOURNAL OF CHILD NEUROLOGY (2004)
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
L Brichta et al.
HUMAN MOLECULAR GENETICS (2003)
Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells
E Tauboll et al.
EPILEPSIA (2003)
Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding
B Pohlmann-Eden et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Effects of valproic acid, carbamazepine, and phenobarbitone on the fatty acid composition of erythrocyte membranes in children
SA König et al.
EPILEPSIA (2003)
Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation
S Dutta et al.
EPILEPSY RESEARCH (2003)
Antiepileptic drug-induced pharmacodynamic aggravation of seizures - Does valproate have a lower potential?
E Hirsch et al.
CNS DRUGS (2003)
Valproate-induced hyperammonemic encephalopathy
A Verrotti et al.
METABOLIC BRAIN DISEASE (2002)
Abnormal alterations in the metabolic patterns of patients on valproate therapy
U Kreher et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Topiramate enhances the risk of valproate-associated side effects in three children
E Longin et al.
EPILEPSIA (2002)
Pharmacological and therapeutic properties of valproate - A summary after 35 years of clinical experience
E Perucca
CNS DRUGS (2002)
Low serum biotinidase activity in children with valproic acid monotherapy
KH Schulpis et al.
EPILEPSIA (2001)
Neuropsychological effects of epilepsy and antiepileptic drugs
P Kwan et al.
LANCET (2001)
GABA levels within the medial preoptic area: effects of chronic administration of sodium valproic acid
JC Dodge et al.
PSYCHONEUROENDOCRINOLOGY (2000)
Share Paper
